These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 8772558
1. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. Siris E, Weinstein RS, Altman R, Conte JM, Favus M, Lombardi A, Lyles K, McIlwain H, Murphy WA, Reda C, Rude R, Seton M, Tiegs R, Thompson D, Tucci JR, Yates AJ, Zimering M. J Clin Endocrinol Metab; 1996 Mar; 81(3):961-7. PubMed ID: 8772558 [Abstract] [Full Text] [Related]
3. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group. Miller PD, Brown JP, Siris ES, Hoseyni MS, Axelrod DW, Bekker PJ. Am J Med; 1999 May; 106(5):513-20. PubMed ID: 10335722 [Abstract] [Full Text] [Related]
5. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone. Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, Stuckey BG, Dhaliwal SS, Bhagat CI, Retallack RW, Kent GN, Drury PJ, Vasikaran S, Gutteridge DH. Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907 [Abstract] [Full Text] [Related]
6. Treatment of Paget's disease of bone with alendronate. Lombardi A. Bone; 1999 May; 24(5 Suppl):59S-61S. PubMed ID: 10321931 [Abstract] [Full Text] [Related]
7. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)]. Jung A, Mermillod B, Schenk R, Courvoisier B, Burkhardt P, Epiney J, Fleisch. Schweiz Med Wochenschr; 1976 Nov 27; 106(48):1667-73. PubMed ID: 827810 [Abstract] [Full Text] [Related]
8. Effective short term treatment of Paget's disease with oral etidronate. Preston CJ, Yates AJ, Beneton MN, Russell RG, Gray RE, Smith R, Kanis JA. Br Med J (Clin Res Ed); 1986 Jan 11; 292(6513):79-80. PubMed ID: 3080099 [Abstract] [Full Text] [Related]
11. Alendronate in the treatment of Paget's disease of bone. Reid IR, Siris E. Int J Clin Pract Suppl; 1999 Apr 11; 101():62-6. PubMed ID: 12669742 [Abstract] [Full Text] [Related]
12. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP). Rashid M, Khairi A, Johnston C. Clin Orthop Relat Res; 1977 Apr 11; (127):94-105. PubMed ID: 410576 [No Abstract] [Full Text] [Related]
13. Short-term variations in bone remodeling biochemical markers: cyclical etidronate and alendronate effects compared. Bettica P, Bevilacqua M, Vago T, Masino M, Cucinotta E, Norbiato G. J Clin Endocrinol Metab; 1997 Sep 11; 82(9):3034-9. PubMed ID: 9284739 [Abstract] [Full Text] [Related]
14. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone. Roux C, Gennari C, Farrerons J, Devogelaer JP, Mulder H, Kruse HP, Picot C, Titeux L, Reginster JY, Dougados M. Arthritis Rheum; 1995 Jun 11; 38(6):851-8. PubMed ID: 7779130 [Abstract] [Full Text] [Related]
17. Hereditary hyperphosphatasia: 20 year follow-up and response to disodium etidronate. Singer F, Siris E, Shane E, Dempster D, Lindsay R, Parisien M. J Bone Miner Res; 1994 May 11; 9(5):733-8. PubMed ID: 8053403 [Abstract] [Full Text] [Related]
20. Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate. Gibbs CJ, Aaron JE, Peacock M. Br Med J (Clin Res Ed); 1986 May 10; 292(6530):1227-9. PubMed ID: 3085789 [Abstract] [Full Text] [Related] Page: [Next] [New Search]